Nurse Anesthetist - CR in Barron, WI Accepting Medicare

7 Nurse Anesthetist - CR nurses found. Showing 1 - 7

Patrick Hampton Lillard, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 1222 E Woodland Ave, Barron, WI 54812 Phone: 715-838-5222

Thomas J Thomsen, Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 1222 E Woodland Ave, Barron, WI 54812 Phone: 715-838-5222

Micah D Zimmerman, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1222 E Woodland Ave, Barron, WI 54812 Phone: 715-537-3166

Justin Kyle Shaughnessy, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1222 E Woodland Ave, Barron, WI 54812 Phone: 715-537-3166

Mr. Jill Maria Nisbit, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1222 E Woodland Ave, Barron, WI 54812 Phone: 715-537-3166

Mr. James Raymond Kiffmeyer, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1222 E Woodland Ave, Barron, WI 54812 Phone: 715-838-5222

Scott Rodney Jameson, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 1222 E Woodland Ave, Barron, WI 54812 Phone: 715-537-3166

News Archive

Idenix Pharmaceuticals makes progress with its HCV development pipeline

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the advancement of its hepatitis C virus development pipeline.

Generic biologics face 'tough, long road to realization'

The development of new generic versions of expensive biologic drugs "faces a long, tough road to realization" because the complex generics "will likely face tough regulatory scrutiny, as well as high development and marketing costs," the Wall Street Journal reports.

Rise in PIP breast implant ruptures sparks fresh fears

According to the Australasian College of Cosmetic Surgery all brands of breast implants carry a risk of rupture. Spokesman Dr Daniel Fleming said a rupture rate of 13.6 per cent over eight years is a normal rate for major brand Mentor.

IMAI reaches agreement in principal to acquire Organic Science for $15M

International Merchant Advisors, Inc. www.imaiinc.com announced today that the company has reached an agreement in principal to acquire its first operating business in the clinical medical marijuana space. IMAI has agreed to acquire Organic Science, Inc. for $15 million in the restricted common stock of IMAI.

Read more Medical News

› Verified 6 days ago